The Arg72 variant also appeared to more effectively interact with HPV-E6 in vitro, and to more easily be degraded through the ubiquitin proteasome pathway, resulting in inactivation of TP53 gene and the induction of HPV-related tumor development (11). Here, TP53 is linked to neoplasm.